Endometrial Cancer
Conditions
Interventions
Disease progression group:None
Sponsors
Jilin Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Endometrial cancer was diagnosed by clinicopathological examination. At least one lesion was evaluable according to RECIST1.1 criteria. Age >= 18 years old; 2.Patients completed at least 2 cycles of PD-1/PD-L1 monoclonal antibody treatment. The relevant clinical data and prognosis of the patients were complete. Informed consent was obtained from all patients before treatment.
Exclusion criteria
Exclusion criteria: 1.Combined with other malignant tumors; 2.Acute and chronic infectious diseases; 3.Patients with previous immune system diseases or severe immune adverse reactions during treatment; 4.Patients with heart, liver, kidney, lung and other body organ dysfunction; 5.Patients with cognitive dysfunction and mental disorders; 6.Patients were lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immunotherapy Efficacy; | — |
Countries
China
Contacts
Public ContactJing Li
Jilin Cancer Hospital
Outcome results
None listed